Back to mobile site

H.C. Wainwright Reiterates Buy Rating on Immunome Inc. (IMNM)

September 11, 2026 6:58 AM EDT Send to a Friend
H.C. Wainwright analyst Andres Y. Maldonado reiterated a Buy rating and $40.00 price target on Immunome Inc. (NASDAQ: IMNM).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login